Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Dibujo del cero en una pared El cero (0) es un numeral de la propiedad par. Es el signo numérico de valor nulo, que en notación posicional ocupa los lugares donde no hay una cifra significativa. Si está …

We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors. Therapeutic Potential of our Platform. © 2025 …

Dec 17, 2025 · Get the latest CERo Therapeutics Holdings, Inc. (CERO) stock price with financials, statistics, dividends, charts and more.

Dec 19, 2025 · CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in …

4 days ago · CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer.

Get CERo Therapeutics Holdings Inc (CERO:OTCQB) real-time stock quotes, news, price and financial information from CNBC.

Our core technology is based on a new class of engineered cells called chimeric engulfment receptors (CERs), which integrate multiple features of both the innate (engulfment and antigen presentation) …

Dec 19, 2025 · CERO's current price target is $45.00. Learn why top analysts are making this stock forecast for CERo Therapeutics at MarketBeat.

CERo, incorporated in Delaware on September 23, 2016, and based in South San Francisco, focuses on genetically engineering immune cells to fight cancer. Since inception, CERo has developed its …